Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Jones

Showing results (501-510 of 586) with videos related to

Pageof 59
Sort By:
Antibiotics (Basel, Switzerland)|August 26, 2023
Ceftobiprole Medocaril Is an Effective Post-Exposure Treatment in the Fischer 344 Rat Model of Pneumonic TularemiaMark M Hahn, Cheryl A Triplett, Michael S Anderson, et al.
Emergency Medicine Australasia : EMA|November 14, 2023
Evaluating the use of clinical decision aids in an Australian emergency department: A cross-sectional surveyZoe A Michaleff, Laetitia Hattingh, Hannah Greenwood, et al.
Healthcare (Basel, Switzerland)|May 5, 2018
A Targeted and Tailored eHealth Weight Loss Program for Young Women: The Be Positive Be Health<i>e</i> Randomized Controlled TrialMelinda J Hutchesson, Robin Callister, Philip J Morgan, et al.
Journal of Paediatrics and Child Health|February 12, 2020
Enteral hydration in high-flow therapy for infants with bronchiolitis: Secondary analysis of a randomised trialFranz E Babl, Donna Franklin, Luregn J Schlapbach, et al.
Leukemia & Lymphoma|February 26, 2008
A >or=1 log rise in RQ-PCR transcript levels defines molecular relapse in core binding factor acute myeloid leukemia and predicts subsequent morphologic relapseSteven Lane, Russell Saal, Peter Mollee, et al.
Australian Health Review : a Publication of the Australian Hospital Association|November 11, 2021
Patient satisfaction with a consumer codesigned lower limb cellulitis leafletJaclyn L Bishop, Mark Jones, James Farquharson, et al.
The Lancet Regional Health. Southeast Asia|March 14, 2024
Coverage gaps in empiric antibiotic regimens used to treat serious bacterial infections in neonates and children in Southeast Asia and the PacificPhoebe C M Williams, Mark Jones, Thomas L Snelling, et al.
Musculoskeletal Science & Practice|May 14, 2026
Prognosis in entry-level physiotherapy programs: An Australian and New Zealand framework for developing knowledge and skills for musculoskeletal practiceNicholas Mullen, Samantha Ashby, Darren Beales, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 19, 2015
Cessation of immunosuppression during chemotherapy for post-transplant lymphoproliferative disorders in renal transplant patientsEmma Taylor, Mark Jones, Matthew J Hourigan, et al.
Journal of Global Antimicrobial Resistance|May 15, 2021
Impact of time to first antimicrobial dose on length of stay and 30-day hospital readmission in patients with lower limb cellulitisJaclyn L Bishop, Mark Jones, James Farquharson, et al.
Pageof 59

Showing results (501-510 of 586) with videos related to

Sort By:
Pageof 59
Antibiotics (Basel, Switzerland)|August 26, 2023
Ceftobiprole Medocaril Is an Effective Post-Exposure Treatment in the Fischer 344 Rat Model of Pneumonic TularemiaMark M Hahn, Cheryl A Triplett, Michael S Anderson, et al.
Emergency Medicine Australasia : EMA|November 14, 2023
Evaluating the use of clinical decision aids in an Australian emergency department: A cross-sectional surveyZoe A Michaleff, Laetitia Hattingh, Hannah Greenwood, et al.
Healthcare (Basel, Switzerland)|May 5, 2018
A Targeted and Tailored eHealth Weight Loss Program for Young Women: The Be Positive Be Health<i>e</i> Randomized Controlled TrialMelinda J Hutchesson, Robin Callister, Philip J Morgan, et al.
Journal of Paediatrics and Child Health|February 12, 2020
Enteral hydration in high-flow therapy for infants with bronchiolitis: Secondary analysis of a randomised trialFranz E Babl, Donna Franklin, Luregn J Schlapbach, et al.
Leukemia & Lymphoma|February 26, 2008
A >or=1 log rise in RQ-PCR transcript levels defines molecular relapse in core binding factor acute myeloid leukemia and predicts subsequent morphologic relapseSteven Lane, Russell Saal, Peter Mollee, et al.
Australian Health Review : a Publication of the Australian Hospital Association|November 11, 2021
Patient satisfaction with a consumer codesigned lower limb cellulitis leafletJaclyn L Bishop, Mark Jones, James Farquharson, et al.
The Lancet Regional Health. Southeast Asia|March 14, 2024
Coverage gaps in empiric antibiotic regimens used to treat serious bacterial infections in neonates and children in Southeast Asia and the PacificPhoebe C M Williams, Mark Jones, Thomas L Snelling, et al.
Musculoskeletal Science & Practice|May 14, 2026
Prognosis in entry-level physiotherapy programs: An Australian and New Zealand framework for developing knowledge and skills for musculoskeletal practiceNicholas Mullen, Samantha Ashby, Darren Beales, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 19, 2015
Cessation of immunosuppression during chemotherapy for post-transplant lymphoproliferative disorders in renal transplant patientsEmma Taylor, Mark Jones, Matthew J Hourigan, et al.
Journal of Global Antimicrobial Resistance|May 15, 2021
Impact of time to first antimicrobial dose on length of stay and 30-day hospital readmission in patients with lower limb cellulitisJaclyn L Bishop, Mark Jones, James Farquharson, et al.
Pageof 59